FDA Adverse Event
Death
Summary report: N
EUFLEXXA 20MG/2ML (6=3 SYR)
MDR report key: 17001773
·
Received May 24, 2023
Report
- Report Number
- MW5117809
- Event Type
- Death
- Date Received
- May 24, 2023
- Date of Event
- December 16, 2022
- Report Date
- May 22, 2023
- Manufacturer
- FERRING PHARMACEUTICALS, INC.
- Product Code
- MOZ
- UDI-DI
- 55566410001
- Adverse Event
- Yes
- Report Source
- Voluntary report
- Reporter Location
- PA, US
- Reporter Occupation
- PHARMACIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
THE PT'S DAUGHTER REPORTS THE PT PASSED AWAY ON (B)(6) 2022. INJECT 1 SYRINGE INTO BILATERAL KNEES ONCE A WEEK FOR 3 WEEKS. PRESCRIBER INFO: (B)(6). REF REPORTS: MW5117808, MW5117810.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1618185 | EUFLEXXA 20MG/2ML (6=3 SYR) | ACID, HYALURONIC, INTRAARTICULAR | MOZ | FERRING PHARMACEUTICALS, INC. | U10185A | 55566410001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 89 YR | Female | Death |